Gifford, Robert J.

SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., Sauter, D., Gifford, R. J., Nakagawa, S., & Sato, K. (2020) · Cell Reports

SARS-CoV-2 and COVID-19 Researchinterferon and immune responses

Cited by 433

CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation

Singer, J., Gifford, R., Cotten, M., & Robertson, D. (2020) · Preprints.org

SARS-CoV-2 and COVID-19 ResearchGenomics and Phylogenetic Studies

Cited by 167

ICTV Virus Taxonomy Profile: Retroviridae 2021: This article is part of the ICTV Virus Taxonomy Profiles collection.

Coffin, J., Blomberg, J., Fan, H., Gifford, R., Hatziioannou, T., Lindemann, D., Mayer, J., Stoye, J., Tristem, M., Johnson, W., et al. (2021) · Journal of General Virology

T-cell and Retrovirus StudiesInfectious Diseases and Mycology

Cited by 67

A novel tamanavirus (Flaviviridae) of the European common frog (Rana temporaria) from the UK

Parry, R. H., Slonchak, A., Campbell, L. J., Newton, N. D., Debat, H. J., Gifford, R. J., & Khromykh, A. A. (2023) · Journal of General Virology

Mosquito-borne diseases and controlAnimal Virus Infections Studies

Cited by 9